Literature DB >> 2173161

Ocular disease associated with Epstein-Barr virus infection.

A Y Matoba1.   

Abstract

Epstein-Barr virus (EBV) is a ubiquitous DNA virus of the herpesvirus genus with a high prevalence rate for antibody (about 90%) in the adult population. It is the most common causative agent of infectious mononucleosis syndrome. During recent years an increasing number of ocular disease entities have been reported to be linked to EBV infection. These entities include oculoglandular syndrome, conjunctivitis, dry eye, keratitis, uveitis, choroiditis, retinitis, papillitis and ophthalmoplegia. While EBV-specific serologic tests can now document recent and past primary infection with EBV and also identify patients manifesting atypical immunologic reactions to EBV, the lack of an animal model, the absence of clear-cut response to therapy and the paucity of documentation by culture render the pathogenesis uncertain or the association questionable in many of these cases.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2173161     DOI: 10.1016/0039-6257(90)90069-8

Source DB:  PubMed          Journal:  Surv Ophthalmol        ISSN: 0039-6257            Impact factor:   6.048


  14 in total

1.  Increased presence of Epstein-Barr virus DNA in ocular fluid samples from HIV negative immunocompromised patients with uveitis.

Authors:  J V Ongkosuwito; A Van der Lelij; M Bruinenberg; M Wienesen-van Doorn; E J Feron; C B Hoyng; R J de Keizer; A M Klok; A Kijlstra
Journal:  Br J Ophthalmol       Date:  1998-03       Impact factor: 4.638

Review 2.  Analysis of ocular fluids for local antibody production in uveitis.

Authors:  J H de Boer; L Luyendijk; A Rothova; A Kijlstra
Journal:  Br J Ophthalmol       Date:  1995-06       Impact factor: 4.638

Review 3.  Viral posterior uveitis.

Authors:  Joanne H Lee; Aniruddha Agarwal; Padmamalini Mahendradas; Cecilia S Lee; Vishali Gupta; Carlos E Pavesio; Rupesh Agrawal
Journal:  Surv Ophthalmol       Date:  2016-12-22       Impact factor: 6.048

4.  Epstein-Barr Virus Neuroretinitis in a Lung Transplant Patient.

Authors:  Yen C Hsia; Peter V Chin-Hong; Marc H Levin
Journal:  J Neuroophthalmol       Date:  2017-03       Impact factor: 3.042

5.  Orbital Epstein-Barr Virus-Positive Polymorphic B-Cell Lymphoproliferative Disorder in an Apparently Immunocompetent Woman.

Authors:  Michael D Abendroth; Michael G Bayerl; Michael J Wilkinson; David F Claxton; Charles S Specht
Journal:  Ocul Oncol Pathol       Date:  2017-08-11

Review 6.  Systemic diseases and the cornea.

Authors:  Ruchi Shah; Cynthia Amador; Kati Tormanen; Sean Ghiam; Mehrnoosh Saghizadeh; Vaithi Arumugaswami; Ashok Kumar; Andrei A Kramerov; Alexander V Ljubimov
Journal:  Exp Eye Res       Date:  2021-01-21       Impact factor: 3.467

Review 7.  Ocular herpes: the pathophysiology, management and treatment of herpetic eye diseases.

Authors:  Lucy Zhu; Hua Zhu
Journal:  Virol Sin       Date:  2014-12-15       Impact factor: 4.327

8.  A case of unilateral optic disc swelling with chronic active Epstein-Barr virus infection.

Authors:  Naoko Aizawa; Toru Nakazawa; Masahiko Shimura
Journal:  Clin Ophthalmol       Date:  2010-09-07

9.  Bilateral Multifocal Chorioretinitis and Optic Neuritis due to Epstein-Barr Virus: A Case Report.

Authors:  Vasileios G Peponis; Irini P Chatziralli; Efstratios A Parikakis; Niki Chaira; Michail C Katzakis; Panagiotis G Mitropoulos
Journal:  Case Rep Ophthalmol       Date:  2012-10-06

10.  Case report: a diagnostically challenging conjunctival mass caused by the Epstein-Barr virus.

Authors:  Jordan V Chervenkoff; Saul N Rajak; Paul G Brittain; David A Wright; Victoria J M Barrett
Journal:  BMC Ophthalmol       Date:  2015-10-07       Impact factor: 2.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.